Friday, 13 November 2026European Markets

Energy Markets

4 articles

2.5 Bcf/d Permian pipeline to boost US Gulf Coast LNG exports by 2029

2.5 Bcf/d Permian pipeline to boost US Gulf Coast LNG exports by 2029

MPLX's Blackcomb Pipeline will add 2.5 billion cubic feet per day of Permian gas to Gulf Coast LNG terminals by end-2028. The connection could increase US LNG available for European buyers as the EU seeks alternatives to pipeline gas imports.

ViaNews Editorial Team (Europe)•
European Natural Gas Prices Surge as Commodities Rally Amid Supply Risks

European Natural Gas Prices Surge as Commodities Rally Amid Supply Risks

European natural gas prices are surging as part of a broader commodities rally driven by macro uncertainty and geopolitical supply concerns. Gold futures hit record highs at $4,200/oz while investors rotate into hard assets amid expectations for Federal Reserve rate cuts. The flight-to-safety movement comes as tech indices end winning streaks and supply risk concerns intensify across energy markets.

ViaNews Editorial Team (Europe)•
European Natural Gas Prices Spike as UK Political Turmoil Compounds Energy Market Volatility

European Natural Gas Prices Spike as UK Political Turmoil Compounds Energy Market Volatility

European natural gas prices surged in late November 2026 amid UK political instability and broader commodity market turbulence. The energy price spike coincided with a flight to safe-haven assets, driving gold futures to record $4,200/oz while Bitcoin dropped 19% for the month. Continental energy markets face mounting uncertainty as macro pressures amplify supply concerns.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com